Send this to a friend

Biostage to withdraw SEC registration

Holliston biotech Biostage is seeking to withdraw a registration statement with the Securities and Exchange Commission filed nearly one year ago after no securities had been issued or sold under the statement.
The paperwork was based on a backstop agreement with a Texas-based investment firm First Pecos LLC in which the firm would purchase $3.1 million worth of Biostage’s shares. 
That offering and inv ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media